Abstract
Following the publication of this article, the authors became aware that an incorrect panel was used for Figure 3B. The correct panel for Figure 3B is below, showing the change in heart rate when mice were challenged with isoproterenol in a murine model of cerebral cavernous malformation treated with vehicle or propranolol. The Figure 3 legend is amended as follows: ∗∗∗P < 0.001, by 2-way repeated-measures ANOVA with a post hoc Tukey's honest significant difference test. The authors have stated that this corrected panel does not affect the results or conclusions of the article. The authors regret the error.
Cite
CITATION STYLE
Li, W., Shenkar, R., Detter, M. R., Moore, T., Benavides, C., Lightle, R., … Awad, I. A. (2021, October 1). Erratum: Propranolol inhibits cavernous vascular malformations by β1 adrenergic receptor antagonism in animal models (J Clin Invest. (2021) 131: 3 (e144893) DOI: 10.1172/JCI144893). Journal of Clinical Investigation. American Society for Clinical Investigation. https://doi.org/10.1172/JCI154909
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.